hg_52650.1

Basic information about the TSS

---

TSS ID: hg_52650.1 Species: human Chr: chr4		Start: 76213553 End: 76213564 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC021892 Distance: -1 GeneID: 950 HGNC/MGI_ID: HGNC:1665 UniProt_ID:

Gene_name: scavenger receptor class B member 2 Gene_symbol: SCARB2 Gene_synonyms: HLGP85 LIMP-2 LIMPII SR-BII Gene_source: HGNC:1665

TATA-Box annotation

---

Distance to TSS:	265
Nearest PromoterID:	NM_005506
Entrez ID:	950
Nearest Unigene:	Hs.349656
Nearest Refseq:	NM_005506
Nearest Ensembl:	ENSG00000138760
Gene Name:	scavenger receptor class B member 2
Gene Alias:	AMRF|CD36L2|EPM4|HLGP85|LGP85|LIMP-2|LIMPII|SR-BII
Gene Description:	scavenger receptor class B member 2
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.721393
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SCARB2 p2@SCARB2 p3@SCARB2 p5@SCARB2 p7@SCARB2
Sample		p1@SCARB2	p2@SCARB2	p3@SCARB2	p5@SCARB2	p7@SCARB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.26	3.31	4.87	0.97	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	4.05	4.05	3.84	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.82	4.44	3.86	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.99	7.28	4.78	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.07	5.17	2.92	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.65	5.62	4.85	0.39	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.45	5.23	7.19	1.09	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.84	4.84	6.78	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.06	6.20	3.21	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	8.11	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.45	5.66	2.83	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	3.66	4.88	2.44	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	50.13	54.64	18.54	7.58	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.04	44.50	16.09	6.62	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.50	45.89	17.78	6.37	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	42.25	40.74	18.36	5.53	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.22	41.93	18.13	6.33	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.34	35.01	23.62	5.91	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	31.99	13.86	4.27	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.42	45.73	20.16	8.27	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.31	46.11	20.05	6.42	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	40.22	43.50	17.61	5.87	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.29	43.56	19.91	7.11	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.10	40.04	19.41	6.31	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.28	46.18	16.25	7.48	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	45.58	43.05	14.24	6.65	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	36.81	44.51	16.48	12.09	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.67	52.34	15.80	7.31	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.60	43.61	16.80	6.95	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.62	47.96	16.65	5.79	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.73	35.17	18.42	5.44	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	38.10	47.48	18.56	6.06	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.11	39.88	18.99	7.17	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	41.56	43.21	14.68	6.93	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.27	47.12	18.32	6.36	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.39	45.61	18.59	6.52	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	39.24	45.17	14.51	7.56	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	36.07	42.92	15.31	7.66	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	43.76	53.21	18.10	6.75	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.13	49.69	18.48	8.16	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	38.35	39.05	14.59	7.53	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.09	44.06	17.13	8.34	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	39.23	51.04	17.72	8.01	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.61	50.35	20.98	8.39	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	41.96	51.60	21.88	10.04	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	40.48	51.88	19.31	5.82	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.46	47.98	19.67	7.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.34	48.88	22.65	10.13	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	45.48	53.14	19.39	8.14	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.22	54.19	16.18	10.51	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	54.31	50.62	18.24	9.63	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.59	52.26	14.68	8.89	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	125.93	27.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	45.42	41.16	14.19	8.52	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.44	44.74	13.59	8.62	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	57.05	36.07	8.39	19.30	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	48.22	37.66	11.02	12.86	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	50.56	53.80	13.94	7.13	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.50	48.50	15.42	8.35	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.98	62.87	12.26	13.20	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	52.88	18.33	7.76	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	34.77	46.55	14.02	4.49	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	53.34	67.67	7.96	30.25	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	56.40	56.06	15.97	12.23	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	56.54	72.46	20.79	7.80	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.79	51.12	15.97	6.39	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	161.64	0.00	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	134.26	31.59	94.77	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.50	46.80	16.09	6.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	52.07	63.47	17.36	7.93	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	61.92	47.85	14.54	7.97	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	75.51	59.61	21.86	7.29	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	83.52	56.61	22.89	7.11	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	63.29	51.98	24.15	6.42	1.83
Adipocyte - breast, donor1	11376-118A8	90.75	31.04	38.49	21.07	1.90
Adipocyte - breast, donor2	11327-117E4	53.42	27.75	26.47	13.96	2.25
Adipocyte - omental, donor1	11473-119C6	92.75	29.39	42.24	19.97	3.05
Adipocyte - omental, donor2	11474-119C7	68.77	29.15	19.43	14.95	2.99
Adipocyte - omental, donor3	11475-119C8	82.73	30.81	29.47	12.73	1.67
Adipocyte - perirenal, donor1	11476-119C9	98.89	44.66	22.33	14.67	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	21.99	9.90	5.50	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	52.84	13.10	17.61	4.52	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	51.61	26.59	43.27	6.95	1.91
Adipocyte differentiation, day04, donor1	13019-139D4	120.28	49.68	55.93	17.99	2.35
Adipocyte differentiation, day04, donor2	13022-139D7	66.92	47.36	23.16	13.13	2.06
Adipocyte differentiation, day04, donor3	13025-139E1	63.84	59.10	34.29	19.79	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	100.52	51.14	42.32	14.11	4.11
Adipocyte differentiation, day08, donor1	13020-139D5	102.87	79.23	102.47	36.36	5.23
Adipocyte differentiation, day08, donor2	13023-139D8	74.88	60.03	40.34	26.79	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	67.71	47.99	27.19	23.99	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	69.55	33.94	29.49	15.02	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	82.76	59.89	64.46	30.36	4.16
Adipocyte differentiation, day12, donor2	13024-139D9	74.09	46.72	36.92	21.35	3.52
Adipocyte differentiation, day12, donor3	13027-139E3	71.34	54.00	46.14	23.56	2.62
Adipocyte differentiation, day12, donor4	13030-139E6	71.25	42.63	45.98	23.14	4.57
Alveolar Epithelial Cells, donor1	11510-119G7	21.22	6.41	10.61	1.99	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	4.30	2.51	0.72	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	4.79	9.58	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	33.10	9.53	14.57	1.44	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	5.02	5.02	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.43	11.51	12.12	1.44	1.44
Anulus Pulposus Cell, donor1	11248-116E6	43.71	30.21	14.65	6.29	0.92
Anulus Pulposus Cell, donor2	11463-119B5	43.35	34.04	12.74	5.63	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	42.23	28.75	13.93	8.09	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	46.02	24.75	13.89	6.51	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	51.37	19.26	14.98	4.28	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	44.54	21.22	13.15	5.98	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	26.56	17.71	8.85	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	33.66	21.78	11.22	3.96	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	42.88	24.69	10.72	5.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	50.49	21.84	10.68	8.25	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	45.73	22.57	13.66	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	42.94	24.10	10.55	4.90	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	45.72	20.32	16.69	5.81	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	47.64	17.55	8.78	3.76	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.53	24.71	17.79	5.27	2.31
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	13.65	13.65	8.19	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	62.73	27.75	17.19	8.44	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	45.54	24.65	11.79	5.89	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	46.86	24.94	15.30	4.53	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	50.52	19.51	14.43	5.08	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	36.09	26.34	9.75	8.78	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	50.75	23.55	12.44	5.81	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	50.43	15.61	12.01	6.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	7.08	35.40	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.97	26.24	16.30	3.77	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	4.19	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	41.75	26.21	19.42	4.37	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	48.57	28.08	13.66	5.69	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	16.96	13.33	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	41.04	27.93	9.69	3.42	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	51.52	27.58	12.61	3.85	2.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	39.23	26.07	15.49	4.13	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.88	22.99	15.01	5.16	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.20	29.90	14.79	7.72	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	39.24	17.12	4.28	4.99	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	23.98	12.28	7.60	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	48.17	20.17	10.84	3.61	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	45.14	22.57	11.88	5.94	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	43.23	24.92	16.27	4.58	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	50.94	22.16	12.23	5.35	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	47.02	23.51	12.71	6.99	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.02	26.32	10.79	3.88	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	45.09	29.21	10.80	5.50	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	42.63	20.88	10.44	4.35	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	41.57	25.51	8.50	8.50	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	43.40	25.94	13.22	5.09	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	50.96	16.21	16.21	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	23.24	16.90	12.68	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.39	27.87	13.72	4.50	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	53.55	18.65	12.63	3.61	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	24.06	12.39	9.48	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	57.47	28.74	14.02	3.68	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	25.50	7.65	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	72.96	26.44	17.54	7.12	2.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	58.84	30.14	14.86	7.02	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	44.06	25.09	13.16	3.98	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	51.63	18.64	6.21	7.65	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	49.45	21.51	17.30	6.43	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	51.88	19.84	15.26	4.58	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.89	22.16	11.63	4.98	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.05	28.33	12.71	6.09	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.89	22.90	12.36	5.09	3.27
Astrocyte - cerebellum, donor1	11500-119F6	20.02	15.84	6.51	3.07	1.11
Astrocyte - cerebellum, donor2	11580-120F5	11.47	7.87	5.65	1.37	1.03
Astrocyte - cerebellum, donor3	11661-122F5	13.00	8.60	5.87	0.84	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	38.00	38.69	22.66	10.46	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	26.37	27.99	14.72	4.69	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	35.05	29.83	18.20	5.52	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.33	1.26	0.34	0.00	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.26	0.63	0.88	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.73	1.14	0.68	0.11	0.00
Basophils, donor1	12241-129G9	14.12	4.18	2.62	0.26	0.26
Basophils, donor2	12242-129H1	25.62	4.33	2.53	2.53	0.36
Basophils, donor3	12243-129H2	20.73	4.70	5.88	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	29.11	1.94	7.98	1.72	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	10.52	0.46	2.29	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	0.00	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	17.57	1.88	3.77	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.65	6.86	5.41	1.66	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.96	9.44	5.30	1.61	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	51.82	5.76	11.88	2.34	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	1.86	0.23	1.16	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.30	10.55	9.27	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	19.72	5.07	5.64	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	19.86	1.86	3.34	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	14.93	2.63	3.29	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	103.03	34.53	52.93	4.25	4.25
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	78.85	44.73	35.25	5.69	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	108.81	35.50	51.61	5.59	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	29.34	13.73	10.12	2.75	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	28.97	17.80	14.79	4.22	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	40.27	11.37	15.87	2.37	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.07	9.37	8.20	2.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.01	14.35	13.80	3.59	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.74	9.67	13.39	4.21	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.66	5.68	7.05	2.55	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.38	9.61	6.59	1.60	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	27.86	4.57	6.75	1.09	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	23.41	13.81	10.54	3.75	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.76	8.45	6.86	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	19.97	11.09	2.22	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.19	7.59	6.10	3.87	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.15	12.37	11.17	3.99	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	33.10	9.37	13.12	4.37	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	23.56	8.24	11.44	0.69	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	28.73	7.46	13.35	3.85	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.50	5.24	10.91	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.22	15.87	6.72	1.61	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	18.14	13.78	8.72	2.79	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	25.67	4.21	5.89	2.95	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.92	9.00	10.47	2.20	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.36	5.28	6.69	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	32.90	4.39	11.85	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.44	12.73	14.30	5.06	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.33	7.81	10.41	0.74	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.63	8.62	9.70	2.37	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.85	11.06	15.56	3.28	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	31.99	8.11	9.04	0.93	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	36.42	7.19	14.62	1.86	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	41.63	8.28	9.81	2.62	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	37.42	4.39	8.55	2.08	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	34.23	5.42	10.83	0.87	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	38.77	7.32	12.30	1.40	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	41.74	4.37	9.95	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	54.18	5.57	10.03	0.67	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	31.90	5.87	12.50	1.79	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	45.45	2.42	12.95	2.42	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	53.27	2.74	9.90	1.47	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	10.16	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	14.24	10.85	3.39	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	10.36	10.36	3.11	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.26	10.66	2.67	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	9.11	1.61	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.21	10.53	2.81	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	8.63	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	5.27	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	24.66	10.68	0.82	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	7.98	2.18	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	22.72	9.59	1.01	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.49	4.04	2.42	2.42	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.19	3.60	2.80	2.80	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	11.04	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	17.42	10.11	3.37	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.16	7.14	7.52	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.17	11.50	8.12	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	26.78	7.50	2.50	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	27.56	3.67	1.22	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	32.33	2.74	2.13	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	15.57	1.02	2.30	0.51	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.05	2.02	2.02	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.66	0.57	1.72	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	20.86	3.32	3.32	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.99	2.81	4.21	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.96	1.16	1.30	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	10.34	1.02	1.19	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.38	0.64	1.45	0.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	14.79	3.14	1.79	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.57	2.45	0.35	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.88	2.20	2.64	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	10.54	0.00	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	14.54	1.25	1.87	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.70	1.00	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.91	5.98	4.35	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	43.41	3.75	8.04	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	7.17	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	11.13	1.85	1.67	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.43	1.73	2.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	14.29	2.52	1.89	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	19.21	1.01	2.53	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.80	2.17	2.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	18.74	2.61	1.31	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	6.93	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	17.54	1.85	1.85	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	5.58	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	23.26	8.58	4.15	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	27.97	8.59	3.44	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	1.54	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	18.62	7.52	5.73	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	8.31	9.69	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	29.14	3.93	2.29	1.64	0.65
CD8+ T Cells, donor2	11307-117C2	28.16	2.63	1.88	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	26.76	5.05	2.02	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.47	3.21	4.36	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.02	5.03	2.88	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.12	3.56	4.92	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.71	4.20	3.60	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.56	4.56	3.60	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.23	4.78	3.18	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.95	5.87	1.96	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.48	3.16	1.58	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.26	3.05	3.52	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.91	9.36	3.32	1.81	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.33	10.75	3.49	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.79	9.06	3.20	1.87	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.76	8.32	2.19	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	8.20	3.64	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	2.98	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.80	4.68	2.16	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.10	5.75	3.74	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.54	5.42	3.06	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.68	4.75	1.90	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	5.54	3.38	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.18	2.89	3.21	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	5.74	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.67	6.70	4.34	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	4.54	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	6.42	3.21	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	9.79	0.00	2.80	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	9.02	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	73.11	20.11	25.59	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	57.31	26.19	20.75	9.88	0.49
Cardiac Myocyte, donor3	11686-122I3	50.72	21.99	25.05	7.05	2.32
Chondrocyte - de diff, donor1	11261-116G1	92.91	29.81	23.23	12.13	2.43
Chondrocyte - de diff, donor2	11338-117F6	90.27	15.99	17.06	8.17	1.07
Chondrocyte - de diff, donor3	11410-118E6	78.62	29.58	26.17	9.78	2.73
Chondrocyte - re diff, donor2	11339-117F7	111.91	46.55	26.86	16.11	2.69
Chondrocyte - re diff, donor3	11411-118E7	72.79	36.40	20.22	6.87	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	105.81	74.02	58.41	23.87	4.13
Ciliary Epithelial Cells, donor2	11323-117D9	76.74	48.95	32.92	13.47	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	70.71	79.47	45.13	19.29	1.68
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	71.62	16.96	31.73	7.61	2.84
Corneal Epithelial Cells, donor1	11526-119I5	12.30	2.42	4.61	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	15.93	5.69	10.24	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.64	2.56	4.60	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.14	17.83	26.09	3.14	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	54.57	15.77	23.97	3.15	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	17.25	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	47.73	13.50	19.11	2.48	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	78.92	83.70	32.80	16.40	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	100.54	79.65	35.25	13.06	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	98.72	88.56	27.10	15.49	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	28.85	23.35	10.67	4.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	28.75	24.64	9.98	4.11	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	39.31	20.08	12.73	4.81	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	25.95	25.95	16.51	3.54	1.97
Endothelial Cells - Artery, donor1	11264-116G4	26.47	21.23	8.14	4.36	0.00
Endothelial Cells - Artery, donor2	11341-117F9	27.76	20.00	9.18	3.06	0.47
Endothelial Cells - Artery, donor3	11413-118E9	21.74	22.44	9.99	4.03	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.03	54.97	15.29	12.63	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	58.42	55.07	18.56	10.65	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.51	45.10	15.22	7.89	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	28.82	26.74	10.99	3.86	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	45.30	21.87	11.98	7.29	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	28.64	23.11	8.79	2.13	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	40.41	36.41	14.00	5.20	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	34.59	20.96	14.15	2.62	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	45.23	48.33	24.23	8.20	2.36
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.80	42.15	14.56	5.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	33.10	27.23	14.66	4.76	0.37
Endothelial Cells - Vein, donor1	11267-116G7	13.65	15.93	3.41	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	32.13	23.75	10.48	5.59	1.40
Endothelial Cells - Vein, donor3	11416-118F3	26.22	27.16	11.62	5.18	1.41
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	9.90	0.00	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.32	3.91	6.84	1.22	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	0.00	10.40	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	78.82	35.71	18.06	6.57	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.23	27.59	13.36	6.35	1.75
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.03	7.37	6.72	0.54	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	47.91	30.56	19.77	9.22	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	51.72	43.40	21.84	17.74	1.77
Fibroblast - Aortic Adventitial, donor2	11326-117E3	51.05	40.92	16.56	9.70	2.85
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	211.85	91.69	44.27	30.56	5.80
Fibroblast - Aortic Adventitial, donor3	11401-118D6	69.10	25.58	24.58	7.31	1.99
Fibroblast - Cardiac, donor1	11268-116G8	39.92	16.78	13.16	5.90	0.45
Fibroblast - Cardiac, donor2	11345-117G4	30.32	15.16	11.37	2.27	3.03
Fibroblast - Cardiac, donor3	11417-118F4	35.96	14.51	13.25	3.79	1.42
Fibroblast - Cardiac, donor4	11452-119A3	66.08	46.07	36.68	13.34	3.64
Fibroblast - Cardiac, donor5	11456-119A7	57.49	35.91	24.11	7.36	1.02
Fibroblast - Cardiac, donor6	11460-119B2	45.63	30.93	21.22	9.40	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	49.58	28.41	18.22	3.62	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.79	26.32	16.83	5.18	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	21.97	21.97	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	16.84	11.99	9.92	2.08	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	54.10	60.55	28.49	14.93	2.71
Fibroblast - Dermal, donor1	11269-116G9	37.33	16.67	11.27	2.82	0.94
Fibroblast - Dermal, donor2	11346-117G5	21.23	14.15	10.85	1.89	1.42
Fibroblast - Dermal, donor3	11418-118F5	36.99	18.62	10.40	1.93	0.48
Fibroblast - Dermal, donor4	11450-119A1	23.63	22.27	11.53	2.83	0.68
Fibroblast - Dermal, donor5	11454-119A5	15.88	26.34	8.20	3.66	0.17
Fibroblast - Dermal, donor6	11458-119A9	18.19	22.25	7.63	4.06	0.49
Fibroblast - Gingival, donor1	11237-116D4	35.19	34.77	14.78	8.33	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	75.72	24.10	23.58	8.91	1.31
Fibroblast - Gingival, donor2	11318-117D4	24.51	17.79	10.41	1.45	0.26
Fibroblast - Gingival, donor3	11394-118C8	41.00	40.61	17.69	8.61	2.13
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	82.07	85.19	47.79	25.97	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	84.75	23.26	23.08	6.17	2.82
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	48.33	33.83	15.59	11.54	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	47.87	22.04	13.12	9.60	2.43
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	62.81	10.23	20.11	3.53	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	68.15	21.79	15.65	7.17	2.34
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	49.50	25.77	15.54	11.59	2.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	41.57	22.27	14.04	7.13	1.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	96.99	29.49	21.72	10.57	1.76
Fibroblast - Lung, donor1	11270-116H1	10.87	9.52	12.23	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	28.35	4.48	5.97	0.00
Fibroblast - Lung, donor3	11419-118F6	28.91	16.67	10.76	4.43	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	30.82	8.33	10.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	12.59	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	4.76	1.96	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	46.28	12.99	14.61	2.84	0.41
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.99	26.38	10.47	7.37	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.18	23.06	11.22	2.88	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.31	33.66	14.38	8.57	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	55.34	28.24	14.88	6.49	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	73.98	17.55	24.30	6.21	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	109.83	28.76	35.84	10.09	2.32
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.90	26.64	22.88	8.07	2.65
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.10	12.80	15.24	1.83	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	5.35	6.01	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	35.98	21.35	13.05	2.37	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	109.34	48.02	22.03	17.66	4.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	80.82	23.80	24.69	5.33	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	85.93	29.37	21.48	10.25	2.37
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	129.67	95.07	27.98	28.28	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	63.69	38.97	17.38	11.55	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	87.82	27.84	14.17	8.10	2.02
Fibroblast - skin normal, donor1	11553-120C5	97.79	23.79	16.41	9.02	3.45
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	107.47	76.59	46.52	40.90	3.01
Fibroblast - skin normal, donor2	11561-120D4	81.27	47.72	19.99	21.20	3.62
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	69.51	29.62	17.23	15.41	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	71.00	20.96	18.56	4.89	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	59.66	27.01	14.19	10.77	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	168.49	73.24	25.95	16.75	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	72.75	35.68	15.66	9.37	2.02
Fibroblast - skin walker warburg, donor1	11554-120C6	51.79	32.89	16.87	9.78	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	66.65	17.56	10.82	9.41	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	132.96	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	60.14	10.46	15.69	6.97	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.46	24.96	14.56	5.72	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.78	18.22	16.40	8.07	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.32	19.42	11.75	4.60	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	5.36	6.12	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	7.66	5.10	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	10.84	9.98	8.56	3.42	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	25.65	21.23	22.34	6.62	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.51	27.17	18.95	3.88	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	12.68	13.27	10.90	2.58	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	19.30	16.65	17.18	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.94	22.83	17.94	3.26	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.50	10.61	6.63	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	10.88	13.43	10.03	1.70	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.02	20.32	14.53	3.20	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.60	13.97	9.40	3.22	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.35	18.46	12.51	1.73	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.26	14.40	8.72	3.60	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.76	10.78	6.51	2.85	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.82	22.13	14.15	3.42	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	18.06	19.68	16.82	3.61	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.49	19.45	9.18	1.97	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	26.30	14.18	2.95	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.14	20.35	18.12	4.13	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.99	16.76	13.41	2.23	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.45	27.02	13.31	3.02	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.52	24.77	19.68	5.94	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.82	23.94	20.66	6.03	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.67	38.71	23.52	6.56	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.86	44.23	19.30	7.00	2.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.20	37.95	21.58	5.98	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.20	28.54	25.46	7.49	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.65	28.38	21.03	11.03	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.17	39.61	19.19	6.60	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	30.90	42.89	22.25	5.30	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.02	33.02	19.18	6.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.13	43.42	21.16	5.29	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.23	51.90	24.60	5.41	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.69	31.28	21.07	4.54	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.92	65.11	26.30	5.77	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.70	40.74	23.78	5.78	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.18	39.39	16.61	4.59	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	51.69	41.96	21.29	9.43	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	36.27	44.32	21.74	6.59	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.28	45.67	19.10	6.59	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	56.67	47.69	23.85	5.89	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	45.00	47.87	20.74	6.85	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	49.47	35.83	23.53	8.82	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	50.80	40.85	19.89	5.81	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.79	35.62	18.65	6.74	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.37	52.05	21.69	8.95	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	46.27	43.69	20.65	7.37	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	44.30	42.99	21.93	7.68	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	52.56	19.83	7.93	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	42.74	38.39	18.60	7.52	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.61	42.17	19.17	6.25	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	64.56	58.71	30.25	10.93	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.55	22.10	5.77	2.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.63	11.09	12.63	3.39	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.46	12.68	10.43	2.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.64	8.45	5.95	1.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.50	9.89	5.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.76	11.07	6.92	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	14.85	9.90	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.06	11.60	7.35	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	11.23	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	17.39	6.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.62	7.81	8.79	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.53	9.06	8.24	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.22	7.55	6.71	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	18.96	10.79	7.52	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	17.62	3.36	9.23	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.95	15.59	7.63	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.23	7.81	5.77	1.02	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	16.71	16.71	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	19.47	13.74	13.74	2.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.25	10.36	7.99	1.48	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	20.33	8.47	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.43	9.94	8.28	2.07	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.50	11.97	7.36	2.53	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.07	13.45	10.76	2.69	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	16.30	15.32	9.13	3.26	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	14.05	7.36	4.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.88	21.58	12.71	3.08	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	20.88	20.88	9.93	2.05	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	22.36	17.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.42	26.90	20.29	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.92	22.33	9.66	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.31	31.54	15.26	2.54	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.52	26.72	10.37	2.39	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	22.69	27.13	17.76	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	30.69	23.61	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.34	32.09	20.42	4.08	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.51	33.36	27.65	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	19.50	9.32	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	21.49	10.15	17.91	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	22.32	14.07	14.56	4.37	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	23.97	13.70	10.27	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.91	33.27	8.73	7.90	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	13.49	7.87	2.25	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	48.84	12.37	10.47	5.07	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	38.85	16.29	7.94	3.34	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.11	3.48	7.77	1.04	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.22	3.04	6.58	0.84	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.47	2.28	7.05	0.91	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.52	3.50	8.20	1.20	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.84	4.51	7.95	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.30	1.72	4.95	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.70	3.36	6.85	0.87	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.13	2.74	5.49	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	15.06	3.84	4.16	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	19.03	11.19	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.88	11.69	8.22	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	13.22	7.93	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.92	6.35	10.58	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.98	6.54	4.36	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.02	15.56	13.11	2.97	1.05
Hepatocyte, donor1	11523-119I2	118.64	7.26	58.11	8.47	2.42
Hepatocyte, donor2	11603-120I1	85.11	34.47	59.25	11.85	2.15
Hepatocyte, donor3	11684-122I1	81.60	23.31	57.67	9.20	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	63.10	16.43	37.05	6.47	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.73	47.47	26.21	16.19	2.47
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	0.00	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	3.33	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	0.00	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4.52	1.29	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2.44	0.81	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.30	0.84	1.26	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	2.41	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	1.85	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	0.94	3.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	1.28	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	0.71	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.85	0.93	1.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	2.09	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	2.62	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	3.20	1.07	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	1.84	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	6.05	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	2.11	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.58	7.34	7.83	3.67	0.16
Keratinocyte - epidermal, donor2	11349-117G8	12.30	4.69	1.76	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	27.17	7.57	6.53	1.70	0.09
Keratinocyte - oral, donor1	11251-116E9	44.61	24.52	14.42	3.41	0.79
Keratocytes, donor1	11527-119I6	16.85	14.44	4.13	3.44	1.03
Keratocytes, donor2	11607-120I5	12.89	9.37	7.03	1.17	0.00
Keratocytes, donor3	11688-122I5	40.51	35.77	12.45	5.53	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	24.18	39.56	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	59.33	32.36	17.26	2.16	2.16
Lens Epithelial Cells, donor2	11609-120I7	95.49	92.15	53.86	21.45	3.11
Lens Epithelial Cells, donor3	11690-122I7	131.49	90.21	51.77	25.33	4.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.28	21.94	14.94	3.91	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.44	17.02	6.42	3.35	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	35.42	22.35	13.69	3.62	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.64	17.74	9.14	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.96	14.18	6.62	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.89	12.83	8.52	3.02	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	30.78	20.11	12.31	2.87	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.43	12.39	7.33	2.53	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.25	10.56	10.27	2.67	2.11
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	20.17	5.93	3.96	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.10	23.85	7.56	4.07	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.85	8.89	5.92	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	30.31	20.91	9.06	3.83	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.56	19.32	8.59	2.15	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.74	10.99	8.52	2.20	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.10	24.64	8.01	5.85	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.72	14.65	3.43	1.87	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.52	9.88	8.42	0.91	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.95	22.05	6.91	3.62	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.35	12.01	4.98	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.43	10.95	8.71	2.49	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.52	20.37	5.82	3.88	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.97	20.20	8.62	3.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.64	16.80	11.05	2.57	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	28.51	19.70	6.22	4.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	21.78	9.21	5.23	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.51	14.89	10.68	2.26	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	18.57	8.94	2.75	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.24	22.01	6.40	4.89	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.83	12.62	8.80	2.12	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	20.35	9.69	4.36	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	14.22	4.96	3.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.80	13.01	7.06	1.86	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.35	31.84	14.07	6.66	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.07	20.01	6.42	3.95	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.07	10.86	7.56	2.75	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.30	27.98	9.33	6.11	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.17	24.65	12.48	3.96	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.63	18.20	13.16	3.36	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.62	25.24	12.80	2.84	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	15.51	4.85	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.45	10.27	5.76	2.33	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.14	26.50	7.88	4.30	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.03	23.52	8.17	3.27	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.60	8.48	7.30	1.18	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	23.39	21.78	12.62	5.57	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.71	11.01	5.89	2.56	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.36	14.92	7.76	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	4.53	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	28.38	4.60	9.21	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	6.68	7.42	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.96	6.35	6.35	1.69	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	3.52	7.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	3.74	5.60	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.52	2.06	5.15	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	5.95	5.95	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.39	4.30	8.60	3.85	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.05	5.82	8.14	2.62	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	5.40	12.15	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.73	6.23	10.84	1.49	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.68	7.19	8.73	2.57	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.76	3.53	10.59	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.32	5.33	6.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	5.09	7.64	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	32.55	7.20	14.67	3.47	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.75	6.42	10.77	2.27	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	4.29	8.59	3.07	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	26.91	6.52	5.71	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.32	8.33	10.20	2.08	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	31.11	7.29	11.21	1.68	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	31.94	5.15	6.18	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.61	7.84	10.74	2.90	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.40	8.67	11.06	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	37.07	6.64	11.62	3.32	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.22	4.60	8.48	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.03	6.27	11.43	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	37.99	3.45	4.61	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	32.62	6.91	10.36	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	7.93	7.93	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	5.74	7.38	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.28	6.78	6.78	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	5.75	6.46	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	34.36	6.72	9.71	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	25.27	6.32	10.40	1.86	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	32.31	5.17	13.35	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.97	5.14	10.28	6.85	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.65	6.33	11.99	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	4.83	8.45	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.04	5.69	8.53	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.47	5.50	8.25	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.93	5.37	10.20	3.76	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	4.71	9.43	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	35.56	6.30	10.00	2.22	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	4.65	5.81	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	4.23	8.46	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.41	3.60	13.20	2.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.89	5.09	8.72	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	4.60	6.90	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	29.60	5.43	8.88	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	4.70	3.76	1.88	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.11	5.53	8.55	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.08	1.80	8.11	1.80	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	3.44	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.61	5.34	9.35	3.12	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.29	4.69	8.21	1.17	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	2.64	5.28	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	2.59	8.30	3.11	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.44	3.06	6.56	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.31	3.91	7.27	2.80	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.03	4.42	7.07	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.30	4.63	8.49	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	24.81	2.53	6.58	2.53	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.95	2.40	9.13	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	23.06	2.39	9.54	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.70	4.86	5.47	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	2.77	6.23	2.08	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.04	6.08	10.26	2.66	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.89	4.65	9.30	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.00	4.84	8.47	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	24.40	7.29	10.46	1.58	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.06	5.33	11.19	2.67	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	32.18	8.05	12.64	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	5.66	5.14	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	8.49	4.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.67	6.24	10.78	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	26.21	5.41	9.57	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	2.35	10.18	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	33.40	5.85	8.35	2.09	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.95	2.79	10.22	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	4.68	10.70	2.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.96	5.88	8.02	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	27.07	5.66	6.06	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	7.34	6.42	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	5.33	9.78	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	7.41	9.69	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	6.90	16.87	3.07	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.94	6.57	14.77	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	26.28	3.12	11.14	1.78	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.08	4.42	10.14	3.12	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	4.64	10.61	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	35.34	0.00	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	105.07	20.06	36.24	3.42	1.82
Macrophage - monocyte derived, donor2	11313-117C8	118.91	50.28	46.43	13.76	2.20
Macrophage - monocyte derived, donor3	11389-118C3	112.86	31.46	47.32	7.34	2.62
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	27.61	7.97	13.81	3.19	2.66
Mallassez-derived cells, donor2	11929-125I3	78.75	20.12	18.54	9.35	2.06
Mallassez-derived cells, donor3	11930-125I4	38.36	19.04	13.62	8.34	0.56
Mammary Epithelial Cell, donor1	11273-116H4	53.21	10.36	13.25	3.59	1.00
Mammary Epithelial Cell, donor2	11350-117G9	43.43	12.16	9.84	4.05	1.16
Mammary Epithelial Cell, donor3	11422-118F9	17.96	4.99	5.49	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	6.10	1.36	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	11.25	2.81	1.84	0.22	0.32
Mast cell, donor2	11565-120D8	31.50	10.10	6.24	0.89	0.30
Mast cell, donor3	11566-120D9	47.50	10.81	5.63	0.68	1.58
Mast cell, donor4	11567-120E1	47.51	6.91	6.21	1.06	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	15.64	5.88	2.66	1.44	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	7.59	2.33	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	16.29	6.65	2.75	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	23.77	2.68	1.51	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	44.28	27.66	26.86	5.97	2.29
Melanocyte - dark, donor2	11582-120F7	55.72	30.80	24.23	6.58	0.69
Melanocyte - dark, donor3	11663-122F7	82.73	22.82	22.67	7.32	1.30
Melanocyte - light, donor1	11274-116H5	51.72	20.22	14.57	7.29	1.18
Melanocyte - light, donor2	11351-117H1	34.12	19.79	7.51	0.68	0.00
Melanocyte - light, donor3	11423-118G1	23.42	11.27	13.88	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	46.34	23.32	19.16	6.04	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	65.35	40.07	19.36	12.64	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	44.73	45.00	13.12	13.12	1.61
Meningeal Cells, donor1	11493-119E8	35.36	18.73	11.91	4.84	1.74
Meningeal Cells, donor2	11573-120E7	42.69	27.29	14.08	3.96	0.88
Meningeal Cells, donor3	11654-122E7	39.69	23.47	14.83	6.85	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.51	26.23	11.12	5.70	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	57.36	20.23	17.31	5.64	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	6.57	3.94	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	0.00	3.92	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	52.39	12.20	15.07	7.89	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	52.31	33.46	24.14	9.53	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.71	34.68	14.07	8.54	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	26.81	7.47	7.25	1.98	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	5.84	5.11	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	22.10	12.07	5.12	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	83.38	44.05	14.82	8.73	1.94
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.02	4.83	7.06	1.49	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	63.95	23.16	25.79	7.89	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.79	10.68	11.87	3.26	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	7.01	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.21	12.17	8.97	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	48.56	20.91	22.33	5.32	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	57.85	25.33	32.52	6.25	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	13.79	10.16	1.45	2.90
Mesothelial Cells, donor1	11247-116E5	70.01	44.02	33.68	10.87	2.12
Mesothelial Cells, donor2	12156-128G5	41.54	44.54	20.02	6.51	1.50
Mesothelial Cells, donor3	11402-118D7	39.02	28.91	16.69	5.49	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	164.74	54.01	39.16	16.20	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	86.44	86.93	41.87	18.47	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	133.68	56.83	55.65	17.96	5.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	96.80	27.66	62.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	70.05	68.81	36.88	9.92	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	102.47	39.00	39.41	9.75	3.11
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	99.59	34.74	32.42	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	68.82	61.06	32.78	12.76	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	121.49	47.94	55.86	9.78	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	38.93	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	64.62	59.14	30.89	11.79	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	108.49	40.39	51.08	12.27	4.36
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	59.86	34.21	25.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	64.60	52.21	20.35	9.73	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	97.26	44.07	46.35	13.30	3.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	86.85	30.27	31.58	6.58	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	65.79	52.00	25.04	11.67	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	92.08	44.20	31.31	8.29	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	61.40	45.60	28.02	11.92	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	77.13	38.56	30.18	6.71	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	67.90	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	50.43	54.20	22.58	12.29	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	87.46	38.03	35.65	15.92	3.09
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	61.92	56.39	27.09	7.19	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	65.85	53.19	20.49	12.66	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	98.23	49.01	46.27	15.57	3.16
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	62.17	39.14	27.72	7.13	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	52.99	47.84	23.60	13.73	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	86.92	44.68	35.12	9.11	3.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	72.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	62.42	54.32	21.24	13.36	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	73.51	42.08	30.42	8.62	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	61.31	39.77	33.14	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	57.35	66.05	23.10	14.13	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	82.93	54.70	37.05	19.12	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	49.06	40.34	25.08	15.26	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	56.71	50.46	25.95	17.30	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	86.45	62.44	50.43	18.41	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	49.36	68.56	21.94	12.34	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	52.06	65.08	26.53	16.02	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	53.89	26.95	80.84	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	48.92	22.42	10.19	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	62.62	98.09	23.65	21.46	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	111.47	70.63	29.80	17.66	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	50.59	72.36	16.01	11.53	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	54.29	102.14	25.04	27.27	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	118.30	87.68	30.62	16.70	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	72.93	95.02	17.68	22.10	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	60.85	115.55	23.93	22.91	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	96.28	94.96	22.32	24.94	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	41.19	90.90	19.53	14.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	49.94	130.46	21.32	28.06	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	102.24	118.45	32.42	34.50	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	53.61	93.82	18.07	18.65	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	49.47	140.27	23.23	22.62	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	126.05	136.90	47.58	30.89	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	86.63	14.44	21.66	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	59.11	142.23	21.24	19.39	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	124.64	132.04	34.15	33.01	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	56.38	96.45	26.53	20.17	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	51.05	147.20	23.84	37.84	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	133.41	123.12	39.04	29.60	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	52.72	71.14	23.50	8.89	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	52.84	137.98	21.35	24.82	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	140.68	106.26	38.31	23.35	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.64	74.16	20.76	13.98	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	62.75	151.29	20.70	32.49	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	140.20	167.62	53.51	41.79	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	58.78	90.63	23.51	15.55	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	68.47	148.87	22.16	27.56	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	129.05	147.73	43.75	29.74	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	50.18	46.92	16.29	7.82	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	69.68	136.72	19.41	24.11	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	130.61	100.63	41.52	21.62	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	85.73	70.06	23.49	9.48	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	71.77	126.56	24.12	25.01	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	64.04	41.44	7.53	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	53.47	39.21	21.39	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	74.91	41.40	27.93	7.56	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	73.64	47.34	31.56	5.26	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	113.27	37.96	34.79	6.13	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	107.10	75.44	39.12	11.18	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	100.27	45.44	37.93	11.64	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	81.77	44.75	40.75	10.92	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	75.33	19.34	20.25	4.86	2.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	54.52	14.00	16.94	2.21	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	74.02	36.64	25.28	5.50	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	87.11	28.00	35.78	6.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	110.09	27.26	33.67	9.09	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	7.73	15.46	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	75.75	34.34	24.24	7.07	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	70.41	51.02	37.10	10.96	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	113.04	44.94	24.51	5.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	38.78	36.24	8.27	9.54	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	59.12	53.45	22.68	10.53	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	45.31	54.38	12.08	13.59	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	5.71	45.68	34.26	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	55.46	16.31	29.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	118.81	147.33	38.02	71.29	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	37.65	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	68.51	32.75	21.33	6.68	2.80
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	55.92	32.40	17.25	2.61	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	43.39	26.70	10.68	8.01	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	59.27	27.13	11.69	3.76	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.89	42.02	11.98	14.07	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	90.96	54.26	14.36	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	15.64	10.20	3.40	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	84.53	14.70	18.38	9.19	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	46.88	30.13	13.39	5.86	3.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	69.03	36.03	14.18	9.53	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	55.13	26.21	18.38	5.94	2.70
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	67.91	23.76	20.18	7.57	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	33.40	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	49.14	28.29	12.91	3.97	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.53	45.47	12.45	6.77	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	49.19	19.49	13.15	4.53	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	57.65	25.80	20.90	9.31	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	73.27	31.71	20.96	9.66	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	54.10	28.11	23.87	7.43	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	54.63	25.81	21.61	3.00	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	52.51	36.76	11.49	16.41	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	49.60	20.00	15.29	4.07	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	77.61	31.22	23.11	8.47	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	63.29	21.10	18.28	6.33	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	82.29	33.56	18.85	3.22	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	61.70	33.42	22.82	9.00	2.89
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	57.25	31.73	13.45	10.00	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	96.08	45.51	20.23	17.70	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	72.63	32.30	21.61	6.46	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	75.79	29.64	16.09	4.66	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	66.93	36.55	14.24	7.12	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	75.55	42.50	25.33	7.73	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	54.17	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	77.31	31.66	26.66	8.66	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	74.39	21.19	19.84	9.02	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	59.52	16.67	12.70	8.33	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	78.93	27.86	29.72	8.36	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	69.24	51.84	16.27	11.73	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	63.22	18.25	18.58	4.89	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	64.93	22.66	21.35	10.02	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	87.29	31.66	22.61	8.14	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	58.21	19.40	14.11	4.41	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	77.79	25.93	23.27	9.97	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	75.89	44.15	31.75	8.93	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	58.19	17.99	14.55	4.59	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	127.33	54.44	39.62	13.31	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	89.07	21.88	24.53	7.96	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	62.34	27.11	24.40	6.10	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	51.10	15.33	30.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	71.94	31.70	23.17	8.54	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	69.24	25.18	20.14	3.78	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	74.76	19.07	14.22	6.05	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	57.75	21.36	24.53	3.16	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	79.36	22.67	17.00	13.60	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	121.39	20.23	25.29	20.23	10.12
Myoblast, donor1	11241-116D8	67.70	27.95	29.07	11.43	2.48
Myoblast, donor2	11322-117D8	78.63	33.75	29.34	11.89	0.96
Myoblast, donor3	11398-118D3	81.73	47.09	33.30	12.28	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.53	8.17	4.67	0.73	0.15
Natural Killer Cells, donor1	11230-116C6	22.76	3.69	4.61	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	23.22	1.81	1.81	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	16.56	2.39	2.94	0.00	0.18
Neural stem cells, donor1	11275-116H6	121.22	47.91	48.63	23.59	6.17
Neural stem cells, donor2	11352-117H2	90.51	50.07	48.14	11.55	0.00
Neurons, donor1	11494-119E9	51.21	25.03	21.62	9.10	1.14
Neurons, donor2	11574-120E8	45.79	39.41	27.96	10.57	2.42
Neurons, donor3	11655-122E8	46.04	32.89	19.73	10.69	2.47
Neutrophils, donor1	11233-116C9	6.50	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	7.94	0.00	1.22	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	52.24	43.58	21.61	9.62	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	39.07	24.42	11.07	2.60	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	36.50	29.48	11.43	1.80	0.40
Olfactory epithelial cells, donor1	11933-125I7	55.34	24.23	13.35	4.54	0.41
Olfactory epithelial cells, donor2	11934-125I8	41.98	22.58	16.07	4.49	1.16
Olfactory epithelial cells, donor3	11935-125I9	45.74	20.66	15.10	5.56	1.48
Olfactory epithelial cells, donor4	11936-126A1	60.58	33.02	22.99	6.82	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	53.56	36.11	37.91	11.43	0.60
Osteoblast - differentiated, donor1	11276-116H7	51.05	12.76	17.65	2.13	1.70
Osteoblast - differentiated, donor2	11353-117H3	60.58	8.00	19.43	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	36.62	11.79	9.93	3.10	0.00
Osteoblast, donor1	11277-116H8	16.61	7.62	5.86	1.76	0.78
Osteoblast, donor2	11354-117H4	52.67	18.26	16.15	4.92	0.70
Osteoblast, donor3	11426-118G4	43.54	18.66	14.40	2.49	1.07
Pancreatic stromal cells, donor1	11249-116E7	37.99	25.27	13.65	8.51	1.10
Pericytes, donor1	11491-119E6	14.13	6.01	6.23	1.00	0.89
Pericytes, donor2	11571-120E5	20.83	9.96	5.89	0.68	0.23
Pericytes, donor3	11652-122E5	37.43	10.58	12.82	1.22	0.61
Perineurial Cells, donor1	11499-119F5	51.76	42.84	23.62	9.95	1.70
Perineurial Cells, donor2	11579-120F4	62.38	32.76	33.12	11.04	2.48
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	34.42	8.92	7.97	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	18.85	7.10	5.14	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.87	2.33	3.36	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	9.09	2.15	4.78	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	14.42	5.54	6.65	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.80	6.28	4.52	1.18	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	50.00	25.95	15.51	10.13	0.95
Preadipocyte - breast, donor1	11467-119B9	69.78	21.76	18.95	10.88	2.81
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.64	20.88	21.01	13.31	0.78
Preadipocyte - breast, donor2	11328-117E5	49.98	35.12	19.81	9.68	1.13
Preadipocyte - omental, donor1	11468-119C1	91.43	30.26	34.21	16.20	3.52
Preadipocyte - omental, donor2	11329-117E6	82.93	25.32	35.35	14.84	2.62
Preadipocyte - omental, donor3	11403-118D8	91.97	29.37	37.10	10.17	3.01
Preadipocyte - perirenal, donor1	11469-119C2	63.98	28.54	26.58	7.87	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	23.34	10.75	6.45	2.46	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	42.85	29.39	15.23	8.85	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	49.38	28.10	20.09	11.41	1.87
Preadipocyte - visceral, donor1	11280-116I2	50.58	29.81	19.10	9.87	1.68
Preadipocyte - visceral, donor2	11357-117H7	48.78	35.43	16.11	9.20	1.84
Preadipocyte - visceral, donor3	11429-118G7	51.51	31.66	11.91	7.52	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	33.94	11.92	24.89	4.53	0.75
Prostate Epithelial Cells, donor2	11331-117E8	24.78	17.60	8.53	4.87	0.95
Prostate Epithelial Cells, donor3	11404-118D9	42.01	8.14	11.21	2.88	1.10
Prostate Stromal Cells, donor1	11254-116F3	45.10	35.54	21.41	15.26	2.51
Prostate Stromal Cells, donor2	11332-117E9	55.58	35.68	23.13	10.76	1.26
Prostate Stromal Cells, donor3	11405-118E1	54.43	37.12	23.88	9.70	1.77
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.44	4.74	12.41	0.36	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	47.89	23.43	24.95	2.98	1.87
Renal Epithelial Cells, donor1	11517-119H5	12.17	5.07	4.06	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.92	4.98	7.11	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	59.50	28.05	28.27	6.03	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	10.21	6.81	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.76	13.34	9.03	1.35	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	44.40	25.31	15.54	4.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	3.99	6.65	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.03	9.46	11.44	1.54	0.66
Renal Mesangial Cells, donor2	11598-120H5	18.81	8.15	12.54	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	11.37	3.33	4.99	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.55	9.39	13.96	2.15	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.72	4.22	7.17	1.69	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.16	8.49	5.59	0.39	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	23.34	24.37	18.15	4.93	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	26.43	20.75	13.64	3.70	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	7.20	4.12	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	47.67	17.06	18.82	2.76	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	111.05	33.54	86.86	20.18	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	90.23	22.34	6.25	5.36	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	41.83	14.31	11.01	9.91	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	77.73	29.00	15.08	16.82	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	40.70	23.01	10.27	3.77	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.49	13.21	11.52	2.18	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	38.15	14.72	15.17	2.90	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	45.15	17.24	15.26	2.73	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.26	18.18	13.05	2.33	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.66	15.49	12.94	1.85	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	40.52	18.76	9.99	1.51	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.92	12.86	11.65	1.51	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	45.34	15.05	15.95	2.33	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	42.75	17.36	11.91	1.86	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.91	13.84	14.17	1.72	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.54	13.05	12.61	1.11	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	44.54	18.35	8.60	1.72	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.51	13.79	12.02	2.61	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.22	12.59	18.04	3.95	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.61	18.05	13.67	1.59	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	31.25	15.38	13.04	1.85	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	34.75	15.28	15.28	1.72	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	41.33	19.22	12.49	2.46	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.04	13.45	12.61	1.40	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.77	15.04	13.67	2.05	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	40.48	16.59	9.85	2.37	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	31.39	13.00	12.26	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.70	14.51	13.43	3.22	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	57.32	19.11	15.80	2.36	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	34.72	13.89	11.71	1.39	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.71	17.54	13.80	0.94	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.11	17.42	10.37	3.11	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	36.06	15.04	13.27	2.65	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	32.38	12.32	11.28	2.51	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	50.60	16.82	13.05	2.15	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.27	14.30	12.94	2.72	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.39	13.69	8.29	1.74	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.05	15.30	9.80	3.09	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.84	14.27	13.31	2.06	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.97	14.78	14.78	1.48	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	44.99	18.24	10.23	3.24	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.96	17.75	12.72	1.33	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	38.92	13.86	13.59	1.87	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	53.51	22.26	10.92	2.49	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.48	16.67	12.62	2.14	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	40.31	20.36	11.89	5.24	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.62	21.10	11.96	3.86	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	51.01	18.17	12.93	3.14	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	51.07	19.64	13.00	3.32	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	55.69	23.38	13.95	4.04	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	61.42	21.98	20.67	8.01	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	53.54	26.77	16.43	6.08	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.76	22.30	12.96	4.52	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	72.61	27.37	26.01	5.65	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	86.87	29.95	23.66	7.49	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	85.37	30.82	22.32	7.67	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	73.00	30.95	24.33	6.40	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	73.92	24.04	19.23	5.41	0.60
Schwann Cells, donor1	11498-119F4	20.69	7.15	4.70	0.56	0.19
Schwann Cells, donor2	11578-120F3	47.63	17.01	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	47.10	21.25	12.49	4.60	0.44
Sebocyte, donor1	11220-116B5	37.80	13.69	9.86	1.10	0.00
Sebocyte, donor2	11301-117B5	19.76	6.89	5.06	1.84	0.00
Sebocyte, donor3	11378-118B1	28.44	12.37	11.34	2.47	1.24
Sertoli Cells, donor1	11255-116F4	71.23	36.45	24.85	24.85	3.31
Sertoli Cells, donor2	11333-117F1	96.03	8.47	16.95	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	35.98	25.43	13.99	6.51	1.76
Skeletal Muscle Cells, donor2	11358-117H8	15.18	5.06	5.78	0.72	2.17
Skeletal Muscle Cells, donor3	11430-118G8	18.39	18.39	7.52	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	29.22	26.39	12.57	3.93	0.94
Skeletal Muscle Cells, donor5	11455-119A6	28.39	31.81	12.93	5.50	1.04
Skeletal Muscle Cells, donor6	11459-119B1	26.78	22.62	11.39	2.62	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.88	34.53	20.16	7.31	2.14
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.53	28.40	15.12	4.14	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.74	19.05	17.26	4.17	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	41.37	23.34	15.42	7.58	2.02
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	13.03	2.90	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.99	14.59	6.33	3.44	0.83
Skin - palm, donor1	10286-104F7	32.23	32.23	21.49	13.43	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.82	5.48	6.63	0.72	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	54.80	3.27	7.36	4.91	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.42	7.53	5.71	0.65	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	44.76	15.29	15.15	3.75	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	30.66	6.05	8.02	1.41	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	51.80	20.72	17.13	4.44	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	47.07	18.81	16.41	4.72	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	29.93	12.96	6.17	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	165.86	132.95	44.69	29.79	7.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	40.56	36.45	12.34	7.64	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	55.25	30.94	23.87	7.51	3.31
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.29	12.99	8.66	1.18	3.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	40.95	30.13	19.31	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	69.05	57.04	42.03	30.02	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	41.65	36.06	13.44	5.86	1.73
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.20	27.04	16.62	8.87	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	55.05	26.25	15.24	5.76	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	34.51	17.91	7.49	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	65.86	25.69	27.47	10.34	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	60.65	22.35	25.63	4.84	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.59	4.07	6.34	0.65	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	70.02	28.92	27.09	10.66	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	49.75	15.91	16.42	4.04	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.84	13.83	4.77	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	44.09	29.20	23.89	5.90	2.65
Smooth Muscle Cells - Colonic, donor2	11320-117D6	39.17	26.69	16.57	4.95	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.04	22.46	23.93	5.98	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	31.55	18.56	13.92	5.10	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	9.70	6.47	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	47.52	27.49	15.54	5.08	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.58	4.10	4.78	1.37	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.83	51.44	28.27	11.39	2.51
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	79.00	23.95	23.95	4.13	2.72
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	132.44	111.96	49.15	30.26	4.78
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	40.46	18.72	11.47	2.42	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	32.85	20.40	11.92	4.77	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	64.58	51.93	18.91	11.98	3.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.24	27.67	24.29	8.39	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	59.10	35.26	20.29	12.18	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	65.28	39.95	22.01	13.27	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.01	15.75	14.25	7.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	21.97	10.34	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	34.42	20.93	12.09	2.79	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.91	22.21	16.16	6.06	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	44.82	39.17	13.16	6.58	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	6.19	7.37	1.18	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.99	27.74	15.83	6.33	1.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	40.64	16.82	9.34	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	31.52	21.88	11.66	3.17	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.63	16.06	8.92	2.80	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	24.44	13.16	6.96	1.88	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.43	22.08	16.35	5.87	1.82
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.32	20.95	20.19	4.36	1.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.81	4.76	5.24	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.58	24.71	9.54	4.40	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	65.40	38.00	20.77	11.71	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.41	21.36	6.44	5.27	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	87.46	39.07	27.60	17.30	4.28
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	88.06	24.59	22.21	10.31	2.64
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	39.43	25.29	8.55	13.76	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	95.94	39.17	22.28	11.14	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	59.90	39.75	21.29	11.36	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	46.87	28.36	8.67	11.03	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	68.57	44.95	15.24	20.57	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	97.43	46.32	35.14	17.17	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	63.12	38.04	15.47	15.47	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	84.34	41.25	23.38	11.92	0.92
Synoviocyte, donor1	11291-117A4	70.19	27.27	22.55	10.60	1.68
Synoviocyte, donor2	11368-117I9	82.47	30.34	31.68	16.76	2.01
Synoviocyte, donor3	11440-118H9	99.19	27.70	28.82	17.87	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	15.72	7.86	4.29	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	5.95	3.96	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.27	6.48	5.09	1.85	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	22.87	9.18	6.67	1.72	1.00
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	6.96	4.25	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	6.87	5.73	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	105.55	38.63	87.22	16.73	4.31
Urethra, donor2	10319-105A4	80.93	25.18	32.37	12.59	0.00
Urothelial Cells, donor1	11520-119H8	27.10	6.91	6.64	1.86	0.80
Urothelial Cells, donor2	11600-120H7	17.22	8.41	6.41	0.40	0.40
Urothelial Cells, donor3	11681-122H7	19.25	5.50	7.33	0.92	0.23
Urothelial cells, donor0	11216-116B1	73.56	32.54	28.31	5.80	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	17.80	3.56	6.23	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	1.43	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.21	4.11	0.68	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.74	3.10	3.79	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	15.11	2.32	2.91	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	2.08	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	1.84	6.42	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	1.83	3.65	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.02	14.68	7.65	2.59	0.49
Wilms' tumor cell line:HFWT	10597-108E3	43.12	29.92	14.08	4.40	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.26	8.38	8.38	0.28	0.00
achilles tendon, donor2	10292-104G4	35.13	10.33	10.33	8.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.22	19.12	7.65	2.29	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.29	2.32	7.20	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	7.72	2.97	3.09	0.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	16.33	4.63	7.89	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.62	1.69	1.69	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	16.28	6.56	6.77	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	23.14	7.62	10.07	0.82	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.97	18.07	3.97	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.77	6.13	7.35	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.47	16.70	6.60	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.15	0.37	1.29	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	31.20	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	22.54	12.32	5.11	0.93	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.27	7.25	6.47	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.43	6.43	8.77	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	2.32	2.79	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.68	3.70	6.58	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	11.05	5.22	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.58	15.36	10.67	1.71	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	27.60	14.25	12.74	3.03	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.40	10.11	13.96	2.65	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.25	2.45	4.23	0.22	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	0.00	5.57	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.91	0.38	3.39	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	17.01	1.31	3.93	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	73.48	16.25	24.73	4.47	2.12
adipose tissue, adult, pool1	10010-101C1	73.06	32.42	40.02	15.51	1.40
adipose, donor1	10184-103D4	24.04	21.70	19.94	2.35	0.59
adipose, donor2	10185-103D5	52.31	57.18	29.20	6.49	1.22
adipose, donor3	10186-103D6	27.77	31.86	21.78	7.62	0.54
adipose, donor4	10187-103D7	17.34	12.13	6.93	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.20	9.47	9.47	0.32	0.79
adrenal gland, adult, pool1	10081-102A9	47.29	0.00	18.19	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.80	8.94	4.54	0.13	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	9.29	8.93	2.14	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	98.07	15.53	41.73	5.56	3.71
amniotic membrane cells, donor2	12236-129G4	62.21	16.91	30.09	6.09	0.00
amniotic membrane cells, donor3	12237-129G5	73.94	9.13	22.10	2.95	1.77
amygdala - adult, donor10196	10167-103B5	85.38	20.16	26.09	2.37	4.74
amygdala, adult, donor10252	10151-102I7	79.69	12.98	57.79	4.06	3.65
amygdala, newborn, donor10223	10360-105E9	39.70	12.59	16.46	8.07	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	39.47	44.82	18.59	8.79	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	13.90	7.28	4.63	1.10	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	60.13	53.78	23.05	7.35	1.00
aorta, adult, pool1	10052-101G7	72.77	20.40	27.07	4.51	2.16
appendix, adult	10189-103D9	39.20	20.96	21.35	5.05	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	56.41	60.53	36.11	15.13	2.75
artery, adult	10190-103E1	76.09	9.51	47.55	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	25.93	18.54	11.30	3.77	0.29
b cell line:RPMI1788	10427-106D4	6.84	18.29	6.10	2.08	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	75.47	32.18	21.64	9.16	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.03	14.29	9.23	1.89	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	29.29	2.01	14.39	1.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.71	1.68	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	66.71	19.23	33.79	7.28	1.63
blood, adult, pool1	10053-101G8	8.86	0.00	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	48.81	17.98	6.85	5.14	0.86
bone marrow, adult	10192-103E3	74.23	33.74	26.99	15.52	1.35
brain, adult, donor1	10084-102B3	84.06	19.48	45.10	5.13	5.13
brain, adult, pool1	10012-101C3	116.37	18.82	65.03	5.01	3.23
brain, fetal, pool1	10085-102B4	56.10	32.06	16.03	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.89	29.73	19.16	10.57	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	89.75	25.71	67.90	8.24	3.62
breast, adult, donor1	10080-102A8	47.98	26.52	39.78	13.26	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.88	5.97	8.89	2.16	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	54.11	48.24	22.26	6.18	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.19	17.04	6.45	1.61	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.10	5.08	6.54	1.45	0.48
carcinoid cell line:NCI-H1770	10703-109H1	18.81	15.52	30.56	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	85.21	52.72	61.03	20.89	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	26.62	23.13	20.60	1.90	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.42	104.08	27.15	23.96	3.73
caudate nucleus - adult, donor10196	10177-103C6	89.80	14.97	42.60	6.91	2.30
caudate nucleus, adult, donor10252	10164-103B2	58.40	13.89	39.82	3.85	2.68
caudate nucleus, adult, donor10258	10379-105H1	85.58	10.70	36.68	6.88	4.58
caudate nucleus, newborn, donor10223	10354-105E3	40.29	11.72	20.14	8.42	2.20
cerebellum - adult, donor10196	10173-103C2	166.06	8.74	26.22	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	72.17	16.01	43.56	5.55	1.71
cerebellum, adult, pool1	10083-102B2	57.95	20.35	20.70	4.83	4.14
cerebellum, newborn, donor10223	10357-105E6	75.56	24.08	32.38	15.78	8.30
cerebral meninges, adult	10188-103D8	70.09	26.47	36.81	7.56	3.53
cerebrospinal fluid, donor2	10294-104G6	37.28	9.50	22.66	2.92	0.73
cervical cancer cell line:D98-AH2	10552-107I3	40.26	4.03	5.46	1.15	0.58
cervical cancer cell line:ME-180	10553-107I4	24.19	19.22	11.27	19.55	0.83
cervix, adult, pool1	10013-101C4	80.00	26.77	34.54	10.29	2.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	48.63	24.11	17.70	8.08	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	30.04	5.23	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.11	11.18	9.57	1.99	0.62
choriocarcinoma cell line:SCH	10785-110H2	22.55	24.89	16.76	2.59	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	17.55	12.10	7.35	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	72.37	18.23	26.78	4.56	1.99
chorionic membrane cells, donor2	12239-129G7	47.93	35.89	29.33	10.44	1.99
chorionic membrane cells, donor3	12240-129G8	62.64	19.78	21.98	1.65	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	12.10	4.23	3.65	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	11.40	3.38	4.65	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	7.19	2.31	2.57	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	6.53	2.18	1.94	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.66	1.02	1.43	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	6.77	1.18	5.01	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	12.25	4.17	10.43	1.04	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.80	16.46	7.31	1.37	0.23
clear cell carcinoma cell line:TEN	10636-108I6	29.32	15.44	9.20	3.64	0.69
colon carcinoma cell line:CACO-2	10513-107D9	37.71	25.81	34.41	9.15	1.28
colon carcinoma cell line:COLO-320	10420-106C6	26.61	50.17	20.14	4.18	0.76
colon, adult, donor1	10082-102B1	74.97	15.47	28.56	11.90	0.00
colon, adult, pool1	10014-101C5	73.67	24.09	48.88	12.10	3.06
colon, fetal, donor1	10070-101I7	56.85	35.23	46.35	16.69	1.85
common myeloid progenitor CMP, donor1	12130-128D6	114.59	18.33	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	9.77	8.50	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.43	8.30	6.79	2.26	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	16.92	10.15	8.04	1.55	0.28
corpus callosum, adult, pool1	10042-101F6	229.31	32.06	200.89	14.48	10.84
cruciate ligament, donor2	10295-104G7	59.97	10.54	15.40	4.05	3.24
diaphragm, fetal, donor1	10069-101I6	50.56	21.67	22.47	8.03	0.00
diencephalon, adult	10193-103E4	132.23	31.68	86.88	10.56	5.28
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.59	3.44	1.84	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	35.65	8.46	12.31	1.54	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.15	11.07	8.67	1.44	0.00
ductus deferens, adult	10196-103E7	62.79	16.94	32.39	4.98	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	33.13	17.28	12.96	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	69.15	37.52	17.66	14.71	2.94
dura mater, adult, donor1	10041-101F5	87.54	21.64	25.93	9.25	2.23
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.44	5.77	7.33	0.89	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	8.17	7.16	9.46	1.72	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	38.85	4.93	3.08	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	23.91	71.74	8.17	3.94	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.38	34.58	4.63	4.32	0.31
embryonic pancreas cell line:2C6	10603-108E9	18.39	24.96	7.88	6.57	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	10.39	7.71	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	34.25	36.25	14.14	5.44	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.46	9.81	11.26	1.13	0.96
epidermoid carcinoma cell line:A431	10426-106D3	26.46	10.78	9.34	3.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.43	4.51	7.59	0.88	0.33
epididymis, adult	10197-103E8	96.07	27.00	35.37	9.63	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.95	23.77	10.29	3.55	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.67	7.08	10.22	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.37	2.75	7.60	1.44	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.93	3.84	8.56	1.18	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.25	3.58	6.83	1.01	0.22
esophagus, adult, pool1	10015-101C6	52.98	10.19	26.12	4.67	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.94	37.57	18.16	5.76	1.25
eye - muscle inferior rectus, donor1	10272-104E2	74.85	7.24	24.15	14.49	2.41
eye - muscle lateral, donor2	10298-104H1	46.29	16.83	33.67	10.52	0.00
eye - muscle medial, donor2	10299-104H2	78.88	10.42	46.13	2.98	4.46
eye - muscle superior, donor2	10297-104G9	69.94	20.64	38.98	11.46	2.29
eye - vitreous humor, donor1	10268-104D7	39.35	23.32	14.57	4.37	1.46
eye, fetal, donor1	10054-101G9	83.90	30.00	38.90	7.88	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	27.70	10.51	10.13	1.54	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.84	14.01	10.68	1.66	0.47
frontal lobe, adult, pool1	10040-101F4	105.83	24.30	71.02	7.60	5.16
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	25.52	7.51	14.11	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	96.65	44.16	32.46	5.39	2.74
gall bladder, adult	10198-103E9	61.81	23.66	29.70	6.76	1.69
gamma delta positive T cells, donor1	11937-126A2	15.57	2.15	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	16.81	4.86	2.61	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	47.52	15.42	18.80	1.90	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	24.18	8.32	9.28	2.32	0.00
gastric cancer cell line:AZ521	10549-107H9	31.81	20.49	20.49	1.64	1.31
gastric cancer cell line:GSS	10560-108A2	20.13	6.41	19.22	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	97.78	33.58	62.60	7.31	6.40
giant cell carcinoma cell line:LU65	10487-107B1	16.06	3.56	5.28	0.34	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	21.55	29.11	10.50	3.36	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	49.38	9.23	15.46	2.99	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	35.57	17.10	7.60	4.54	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.05	19.24	11.24	3.51	0.98
glioblastoma cell line:T98G	10485-107A8	27.81	25.72	12.03	6.73	1.43
glioma cell line:GI-1	10413-106B8	37.20	51.25	24.60	9.66	1.17
globus pallidus - adult, donor10196	10175-103C4	165.46	21.14	82.37	10.20	4.37
globus pallidus, adult, donor10252	10161-103A8	146.46	14.16	133.76	3.66	6.10
globus pallidus, adult, donor10258	10367-105F7	134.18	10.95	50.66	5.48	6.85
globus pallidus, newborn, donor10223	10364-105F4	107.65	19.19	50.63	5.86	5.33
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	7.34	29.37	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	50.24	47.36	20.16	13.12	0.64
hIPS +CCl2, biol_rep1	14383-156B9	10.10	11.02	6.43	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	13.26	5.03	5.49	4.12	1.37
hIPS +CCl2, biol_rep3	14385-156C2	13.53	11.59	6.44	3.86	0.00
hIPS, biol_rep1	14380-156B6	8.62	5.75	0.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	9.60	13.72	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	123.59	16.55	28.69	2.21	4.41
hairy cell leukemia cell line:Mo	10712-109I1	5.46	3.74	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	68.46	15.55	30.49	9.87	1.79
heart - pulmonic valve, adult	10206-103F8	64.85	10.72	20.92	4.45	1.05
heart - tricuspid valve, adult	10207-103F9	62.45	14.15	54.95	5.83	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	65.09	13.88	31.42	2.86	2.04
heart, adult, diseased, donor1	10051-101G6	83.89	7.24	42.16	2.55	4.68
heart, adult, pool1	10016-101C7	68.99	13.11	45.54	5.29	1.84
heart, fetal, pool1	10046-101G1	59.14	19.00	30.60	7.08	2.26
hepatic mesenchymal tumor cell line:LI90	10778-110G4	66.02	32.09	25.30	4.32	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	17.84	3.57	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.97	4.97	10.17	0.99	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.64	4.85	7.77	1.09	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	24.25	3.74	9.50	1.82	0.71
hepatoma cell line:Li-7	10484-107A7	25.91	19.57	26.36	7.23	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	74.76	12.30	27.44	4.73	4.73
hippocampus, adult, donor10252	10153-102I9	97.97	14.49	65.11	6.12	4.08
hippocampus, adult, donor10258	10374-105G5	156.36	17.93	17.93	3.98	1.00
hippocampus, newborn, donor10223	10363-105F3	53.22	12.34	18.33	3.88	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	16.48	9.16	6.10	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.03	10.41	8.25	1.57	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.92	11.68	5.84	3.30	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	16.35	12.41	16.35	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	20.92	9.81	17.82	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	14.80	11.01	13.67	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.20	23.36	20.44	5.55	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	29.94	35.33	29.30	5.39	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.45	23.77	20.85	3.34	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.18	22.02	18.71	7.34	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.25	28.29	22.50	7.07	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	33.67	35.01	13.47	11.45	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.17	7.67	5.16	1.56	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	6.39	5.90	2.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	16.58	12.22	6.98	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	23.48	15.27	17.56	1.91	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.91	11.77	15.70	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	27.49	20.99	12.99	3.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	59.72	58.59	30.52	11.12	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	70.48	66.84	34.10	14.55	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	65.47	66.41	28.19	13.78	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.15	54.87	24.33	13.88	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.97	56.90	20.61	16.84	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.62	62.18	20.92	16.44	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.68	9.05	9.05	1.85	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.13	8.56	8.56	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	13.47	10.62	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.11	18.66	17.60	2.11	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.34	11.72	13.30	1.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.37	14.53	17.85	2.12	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.92	36.20	36.72	7.76	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.74	37.86	33.87	11.29	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	49.77	28.99	21.04	6.41	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.46	29.66	18.66	6.65	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	72.69	45.43	25.75	9.84	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.33	31.93	17.81	6.39	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	10.14	6.52	9.18	1.93	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.80	11.14	5.35	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.34	6.83	5.37	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	24.14	12.22	20.48	1.83	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	35.79	13.01	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.50	16.22	12.58	3.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	39.41	26.27	7.11	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.04	39.81	25.69	8.32	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	50.53	31.67	25.27	7.83	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	25.06	16.71	9.55	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	51.46	44.55	30.61	13.00	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.75	30.17	14.55	5.66	1.62
immature langerhans cells, donor1	11904-125F5	5.33	1.21	0.73	0.24	0.24
immature langerhans cells, donor2	11905-125F6	6.34	3.17	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	101.35	16.84	60.57	6.72	5.30
keratoacanthoma cell line:HKA-1	10791-110H8	22.76	8.13	4.55	4.23	0.98
kidney, adult, pool1	10017-101C8	69.69	21.73	26.23	8.41	1.10
kidney, fetal, pool1	10045-101F9	70.31	25.96	30.70	8.91	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.51	22.87	11.65	2.84	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.66	8.29	9.82	1.66	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.88	19.08	6.97	2.20	0.37
left atrium, adult, donor1	10079-102A7	59.39	16.89	22.88	4.90	4.36
left ventricle, adult, donor1	10078-102A6	42.98	12.14	22.25	5.06	0.51
leiomyoblastoma cell line:G-402	10721-110A1	19.70	25.72	8.48	1.37	0.27
leiomyoma cell line:10964C	10569-108B2	59.28	24.07	19.04	3.95	0.72
leiomyoma cell line:15242A	10570-108B3	51.63	17.93	14.67	5.43	1.09
leiomyoma cell line:15425	10571-108B4	51.72	37.15	16.51	10.20	3.40
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	38.10	19.05	19.05	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	32.41	18.82	4.18	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.69	3.54	3.78	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	68.11	46.71	23.12	14.06	2.19
liposarcoma cell line:SW 872	10726-110A6	31.68	33.87	10.72	4.39	0.49
liver, adult, pool1	10018-101C9	97.24	23.17	80.54	8.75	3.73
liver, fetal, pool1	10086-102B5	32.92	20.70	40.45	4.70	0.00
locus coeruleus - adult, donor10196	10182-103D2	116.22	14.29	78.45	5.54	5.98
locus coeruleus, adult, donor10252	10165-103B3	105.56	14.03	79.17	2.95	4.43
locus coeruleus, adult, donor10258	10375-105G6	118.22	18.90	57.56	2.82	3.67
locus coeruleus, newborn, donor10223	10362-105F2	44.59	9.67	26.08	3.36	2.10
lung adenocarcinoma cell line:A549	10499-107C4	15.50	10.24	9.41	1.80	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	4.83	9.65	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	64.33	45.21	30.19	5.93	1.05
lung, adult, pool1	10019-101D1	71.47	29.30	52.33	10.51	2.72
lung, fetal, donor1	10068-101I5	167.53	66.79	65.93	28.26	5.99
lung, right lower lobe, adult, donor1	10075-102A3	66.90	28.87	37.57	5.50	5.04
lymph node, adult, donor1	10077-102A5	38.82	17.99	21.77	4.73	3.31
lymphangiectasia cell line:DS-1	10727-110A7	30.25	86.36	24.11	8.99	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.83	1.81	0.45	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	22.09	11.89	6.80	1.70
mature adipocyte, donor1	12231-129F8	132.31	15.10	50.61	5.77	3.55
mature adipocyte, donor2	12232-129F9	102.10	21.79	50.84	11.21	5.40
mature adipocyte, donor3	12233-129G1	82.50	18.02	30.58	5.93	3.08
mature adipocyte, donor4	12234-129G2	96.07	12.11	36.32	6.84	2.63
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.46	25.26	18.11	3.10	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	92.50	20.30	37.23	5.64	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	85.15	15.26	59.03	4.23	2.57
medial frontal gyrus, adult, donor10258	10368-105F8	105.15	16.52	33.36	7.31	4.13
medial frontal gyrus, newborn, donor10223	10352-105E1	52.03	9.38	10.24	6.82	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	86.23	11.31	47.76	4.56	5.23
medial temporal gyrus, adult, donor10252	10156-103A3	92.11	15.28	70.67	4.03	5.09
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	333.24	11.56	30.82	15.41	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	28.71	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	47.38	12.56	16.87	4.31	0.72
medulla oblongata - adult, donor10196	10174-103C3	112.27	13.63	52.57	5.84	5.84
medulla oblongata, adult, donor10252	10155-103A2	98.76	15.94	83.44	4.33	6.66
medulla oblongata, adult, pool1	10038-101F2	142.03	28.08	96.97	10.77	7.26
medulla oblongata, newborn, donor10223	10361-105F1	75.34	14.23	28.12	5.21	1.39
medulloblastoma cell line:D283 Med	10838-111E1	23.25	52.47	47.16	11.29	0.89
medulloblastoma cell line:ONS-76	10759-110E3	16.87	14.67	5.75	1.35	0.37
melanoma cell line:COLO 679	10514-107E1	46.57	37.52	20.84	7.47	2.16
melanoma cell line:G-361	10465-106H6	100.44	33.66	23.62	6.52	2.71
meningioma cell line:HKBMM	10691-109F7	42.51	29.85	20.44	5.61	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	21.15	22.03	12.34	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	42.51	21.77	29.03	5.44	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	46.80	19.33	16.11	4.60	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.72	22.72	14.00	5.09	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	51.76	31.06	13.25	14.49	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	50.01	27.81	16.15	6.88	1.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	82.80	32.54	27.92	10.40	2.31
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	123.55	46.50	38.17	19.43	6.25
mesenchymal precursor cell - cardiac, donor1	11752-123G6	62.47	46.17	22.14	12.36	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	71.88	47.39	31.17	15.99	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	50.40	22.42	12.73	3.98	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	74.41	40.78	24.31	10.13	2.16
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.84	40.54	18.49	8.82	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	36.56	40.18	12.84	8.23	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	46.08	29.61	16.33	6.64	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	78.54	43.64	25.48	15.01	3.84
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	47.57	49.61	18.37	10.21	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	47.81	31.63	9.71	6.11	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	62.69	45.21	21.83	6.21	1.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.15	23.71	14.82	6.16	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	46.99	41.12	10.91	10.49	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.17	23.01	11.51	2.99	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	40.61	33.87	18.38	5.25	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	75.84	37.92	25.77	8.84	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	45.79	29.76	14.88	6.30	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	46.73	21.47	10.95	8.00	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.00	16.90	7.76	4.57	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.11	19.70	14.32	7.16	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	50.78	16.23	13.87	7.07	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	47.75	16.33	11.71	5.85	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	38.36	17.18	11.30	4.24	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.01	16.25	9.48	4.74	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	43.23	20.83	14.54	5.89	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.61	16.68	6.95	7.88	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	56.24	19.90	14.71	6.63	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	51.54	19.86	12.27	6.69	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	43.26	15.62	14.90	6.49	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	58.67	27.87	11.73	8.07	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	37.59	16.78	15.10	6.71	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	55.68	20.06	12.69	7.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	45.53	13.32	13.32	5.15	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	27.34	13.67	19.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	25.82	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.39	21.11	10.07	9.42	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	78.57	24.73	14.55	4.36	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	67.17	22.92	13.86	3.73	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	48.25	12.27	12.27	9.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	54.42	22.55	18.66	6.22	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	25.18	12.59	8.39	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	85.44	15.90	9.93	8.94	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	90.58	14.30	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	58.70	21.94	20.75	6.52	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	64.58	23.15	10.97	3.66	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	62.70	21.54	12.67	6.33	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	59.67	17.59	12.76	4.14	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	79.52	12.90	15.04	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	27.94	11.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	6.89	24.11	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	51.75	11.82	15.48	4.89	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	49.26	18.27	14.30	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	51.29	19.45	12.97	10.02	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	55.80	20.57	23.07	8.42	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	60.15	21.39	17.38	8.02	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	66.23	20.11	23.65	11.83	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	84.74	10.27	48.79	12.84	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.01	30.98	31.67	14.46	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	92.53	52.94	84.61	19.79	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	93.09	52.71	74.02	15.70	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	89.68	58.52	71.24	23.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	94.30	62.46	76.16	28.21	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	85.04	82.86	87.22	32.71	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	82.36	50.68	50.68	16.47	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	71.61	40.05	44.91	17.60	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	99.42	45.19	49.71	18.08	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	66.72	46.95	65.89	14.00	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	96.24	30.76	49.80	14.09	4.37
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	68.14	30.50	41.54	9.73	3.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	84.55	16.30	34.63	13.24	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	52.61	32.50	15.47	7.74	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.90	59.30	26.70	6.14	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.16	8.34	8.34	0.70	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	17.09	12.82	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.83	13.25	7.09	4.42	0.51
mesothelioma cell line:Mero-25	10850-111F4	12.26	4.09	2.72	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	30.31	7.58	7.82	2.20	0.73
mesothelioma cell line:Mero-48a	10852-111F6	31.89	11.51	4.21	2.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	37.32	21.81	14.72	3.68	1.31
mesothelioma cell line:Mero-83	10854-111F8	21.62	8.34	5.28	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	7.08	2.02	5.06	0.76	0.51
mesothelioma cell line:Mero-95	10856-111G1	31.68	16.36	10.97	4.14	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	37.77	14.91	12.75	3.98	0.33
mesothelioma cell line:NCI-H226	10846-111E9	16.83	3.62	5.43	0.54	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	18.28	12.98	7.17	1.71	0.85
mesothelioma cell line:NCI-H28	10845-111E8	9.67	4.33	3.82	0.76	0.51
mesothelioma cell line:No36	10857-111G2	14.03	2.94	4.24	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	35.22	10.03	9.48	1.63	0.27
migratory langerhans cells, donor1	11901-125F2	6.91	6.33	0.77	1.15	0.00
migratory langerhans cells, donor2	11902-125F3	15.26	5.62	3.05	1.10	0.24
migratory langerhans cells, donor3	11903-125F4	12.92	1.79	1.62	0.36	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	43.42	27.42	16.00	5.22	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.09	23.10	16.95	4.66	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.73	7.37	7.14	0.46	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.61	4.38	4.00	0.19	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.75	5.36	4.25	0.00	0.55
myeloma cell line:PCM6	10474-106I6	28.27	22.53	7.12	3.16	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	20.29	4.06	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	46.49	20.40	9.61	5.88	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.57	9.03	14.49	2.23	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.71	9.78	11.69	2.79	0.81
nasal epithelial cells, donor2	12227-129F4	46.92	10.49	18.77	1.66	0.55
neuroblastoma cell line:CHP-134	10508-107D4	25.54	98.01	37.04	13.57	1.15
neuroblastoma cell line:NB-1	10539-107G8	52.20	55.19	39.10	18.52	2.62
neuroblastoma cell line:NBsusSR	10607-108F4	14.76	13.08	10.12	1.90	0.42
neuroblastoma cell line:NH-12	10555-107I6	38.02	39.88	14.54	5.59	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	19.22	29.89	8.54	3.80	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.00	21.54	8.39	6.49	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	13.89	20.13	8.86	0.60	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.35	26.07	4.45	6.36	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	53.50	29.28	18.37	5.06	2.13
neutrophil PMN, donor1	12133-128D9	89.25	0.00	44.62	0.00	14.87
neutrophil PMN, donor2	12137-128E4	13.28	0.00	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	36.02	8.29	10.82	0.34	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	59.24	35.22	58.44	11.21	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	60.59	25.01	21.80	5.77	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	73.31	45.20	23.65	9.99	2.63
nucleus accumbens, adult, pool1	10037-101F1	97.11	21.09	65.80	6.28	4.41
occipital cortex - adult, donor10196	10172-103C1	119.50	10.30	43.27	8.24	4.12
occipital cortex, adult, donor10252	10163-103B1	84.00	12.08	75.68	4.56	5.37
occipital cortex, newborn, donor10223	10355-105E4	52.77	12.01	17.83	5.10	1.46
occipital lobe, adult, donor1	10076-102A4	113.62	27.03	75.83	7.61	6.04
occipital lobe, fetal, donor1	10073-102A1	98.26	57.50	48.06	13.73	6.01
occipital pole, adult, pool1	10036-101E9	92.40	19.47	55.11	4.97	4.18
olfactory region, adult	10195-103E6	94.57	17.96	49.86	4.78	6.11
optic nerve, donor1	10277-104E7	322.17	48.03	166.09	6.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	42.83	9.57	18.23	2.28	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	15.66	18.55	9.75	1.51	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.53	6.94	4.40	1.69	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	11.90	9.47	3.12	1.62	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	78.49	36.75	20.87	6.47	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	14.95	2.80	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	29.90	23.33	16.96	4.03	1.48
ovary, adult, pool1	10020-101D2	63.33	27.08	34.68	7.95	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	35.38	10.45	15.03	1.47	0.73
pancreas, adult, donor1	10049-101G4	75.25	36.68	35.74	4.70	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.13	21.24	13.70	2.24	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	26.58	19.42	10.05	5.96	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	59.11	23.51	21.53	3.81	1.32
paracentral gyrus, adult, pool1	10035-101E8	112.02	23.89	76.51	7.96	5.77
parietal cortex, adult, donor10258	10373-105G4	100.56	7.34	19.82	0.73	6.61
parietal lobe - adult, donor10196	10171-103B9	92.17	10.35	60.19	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	85.80	15.11	49.31	3.99	3.71
parietal lobe, adult, pool1	10034-101E7	107.24	17.36	72.26	5.90	4.67
parietal lobe, fetal, donor1	10072-101I9	83.41	69.83	44.61	13.58	7.76
parietal lobe, newborn, donor10223	10356-105E5	55.33	12.34	23.55	4.49	2.99
parotid gland, adult	10199-103F1	139.37	16.65	99.28	5.55	1.85
penis, adult	10200-103F2	68.21	16.11	28.47	9.13	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.37	24.92	1.67	3.72	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.87	10.78	8.16	1.46	0.58
pineal gland - adult, donor10196	10179-103C8	185.77	38.06	94.82	12.26	1.94
pineal gland, adult, donor10252	10160-103A7	215.57	49.75	153.38	11.25	13.03
pineal gland, adult, donor10258	10377-105G8	236.41	37.62	100.33	13.80	8.78
pituitary gland - adult, donor10196	10180-103C9	54.64	10.12	16.19	7.08	0.00
pituitary gland, adult, donor10252	10162-103A9	62.54	13.03	44.30	6.25	1.56
pituitary gland, adult, donor10258	10378-105G9	67.25	9.36	7.66	5.11	3.40
placenta, adult, pool1	10021-101D3	104.17	26.66	42.79	14.30	2.04
plasma cell leukemia cell line:ARH-77	10840-111E3	8.61	8.87	3.84	0.53	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	53.23	56.34	30.04	10.27	1.09
pons, adult, pool1	10033-101E6	128.41	24.87	87.87	10.76	5.25
postcentral gyrus, adult, pool1	10032-101E5	99.21	20.05	61.46	8.37	4.71
promyelocytes/myelocytes PMC, donor1	12132-128D8	37.65	6.27	14.64	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.46	15.88	12.24	2.62	0.58
prostate cancer cell line:PC-3	10439-106E7	27.77	11.62	17.06	2.72	1.09
prostate, adult, pool1	10022-101D4	78.81	28.39	61.94	11.52	3.36
putamen, adult, donor10196	10176-103C5	68.69	17.00	41.31	4.49	2.83
putamen, adult, donor10252	10152-102I8	121.56	15.69	70.59	5.88	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	91.80	14.21	7.65	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	82.63	18.12	28.03	2.17	3.38
putamen, newborn, donor10223	10365-105F5	35.23	8.25	9.75	10.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	26.18	20.95	13.38	3.78	1.16
rectum, fetal, donor1	10067-101I4	75.11	69.55	44.51	12.52	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.70	12.30	13.78	1.27	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	60.06	103.97	45.98	13.25	1.66
retina, adult, pool1	10030-101E3	78.82	24.75	39.56	8.95	1.89
retinoblastoma cell line:Y79	10475-106I7	23.64	51.18	48.84	6.24	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	9.59	4.55	2.58	0.37	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	10.40	25.31	15.75	2.81	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	45.47	80.33	18.19	17.43	1.52
salivary acinar cells, donor1	11771-123I7	25.25	22.01	14.24	5.50	0.32
salivary acinar cells, donor2	11772-123I8	39.79	14.73	10.19	6.61	1.10
salivary acinar cells, donor3	11773-123I9	47.67	11.92	10.59	7.28	0.00
salivary gland, adult, pool1	10093-102C3	120.11	24.59	82.93	7.44	8.58
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.54	16.95	5.99	2.70	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.93	16.10	5.17	3.53	0.35
seminal vesicle, adult	10201-103F3	94.70	12.17	33.33	5.29	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	19.19	8.75	6.32	0.97	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	24.66	14.09	13.84	3.27	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	33.12	9.03	11.04	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	55.07	12.76	20.69	0.67	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	46.64	11.94	16.91	2.54	1.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	40.26	7.23	15.74	3.23	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	59.58	12.77	66.68	3.55	2.13
skeletal muscle, adult, pool1	10023-101D5	62.25	20.99	76.40	6.72	4.80
skeletal muscle, fetal, donor1	10066-101I3	30.15	22.11	18.09	4.02	1.01
skin, adult, donor1	10074-102A2	40.71	13.57	13.57	13.57	0.00
skin, fetal, donor1	10065-101I2	58.07	28.41	26.51	10.10	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	25.01	14.68	13.34	4.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.80	36.88	26.48	5.36	3.15
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.38	16.58	6.17	1.35	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	58.18	67.74	42.69	21.43	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	21.07	54.69	64.66	3.22	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	86.51	68.86	45.11	15.47	2.62
small intestine, adult, pool1	10024-101D6	69.16	32.25	40.73	21.02	1.79
small intestine, fetal, donor1	10064-101I1	42.26	61.67	29.97	17.20	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	73.34	11.28	29.24	5.13	3.08
smooth muscle, adult, pool1	10048-101G3	64.10	14.99	23.00	3.88	2.07
somatostatinoma cell line:QGP-1	10781-110G7	90.32	53.87	30.29	6.97	1.34
spinal cord - adult, donor10196	10181-103D1	167.24	17.43	94.97	6.65	9.18
spinal cord, adult, donor10252	10159-103A6	120.25	15.38	85.56	4.73	4.73
spinal cord, adult, donor10258	10369-105F9	156.35	15.22	24.21	9.69	6.92
spinal cord, fetal, donor1	10056-101H2	120.75	32.32	79.28	12.81	8.54
spinal cord, newborn, donor10223	10359-105E8	126.74	15.15	46.38	8.73	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.95	17.92	15.68	3.88	1.05
spleen, adult, pool1	10025-101D7	59.80	29.74	31.83	10.35	1.54
spleen, fetal, pool1	10044-101F8	56.41	25.43	24.63	8.50	1.91
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.97	17.18	4.14	4.45	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	28.86	22.60	15.57	3.04	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	61.85	19.57	30.05	2.45	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.67	19.94	6.65	2.35	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.42	9.12	26.00	2.14	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	48.71	9.32	27.11	6.35	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.88	15.65	17.77	4.23	0.85
stomach, fetal, donor1	10062-101H8	57.67	39.52	18.16	19.22	3.20
submaxillary gland, adult	10202-103F4	71.21	33.04	61.53	8.55	2.28
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	151.21	14.12	128.57	4.57	6.23
substantia nigra, adult, donor10258	10371-105G2	148.45	20.17	33.10	5.69	3.62
substantia nigra, newborn, donor10223	10358-105E7	100.33	17.66	36.04	7.07	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.76	18.34	10.78	3.21	0.46
temporal lobe, adult, pool1	10031-101E4	92.32	19.67	52.30	5.17	4.32
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	63.39	40.60	35.61	10.68	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	63.73	33.84	28.13	7.91	3.96
tenocyte, donor1	11763-123H8	92.51	37.35	23.74	8.03	1.75
tenocyte, donor2	11765-123I1	114.83	32.81	25.56	17.93	1.91
tenocyte, donor3	11768-123I4	77.47	12.97	19.27	6.30	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.63	8.50	4.25	1.53	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	4.01	12.02	4.62	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	11.47	16.58	12.24	2.17	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	7.24	5.33	5.46	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	14.75	3.78	6.43	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.69	6.76	8.29	2.18	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.21	1.63	2.93	0.00	0.00
testis, adult, pool1	10026-101D8	67.75	26.74	34.14	8.91	2.47
testis, adult, pool2	10096-102C6	60.45	21.20	14.89	4.96	2.26
thalamus - adult, donor10196	10168-103B6	186.57	16.56	103.77	3.31	11.04
thalamus, adult, donor10252	10154-103A1	147.06	11.10	124.24	6.56	9.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	428.01	15.40	38.49	1.54	10.78
thalamus, adult, donor10258, tech_rep2	10370-105G1	84.65	9.88	39.53	3.29	2.47
thalamus, newborn, donor10223	10366-105F6	42.57	5.18	16.11	6.90	2.88
throat, adult	10209-103G2	63.17	10.24	28.71	4.49	3.25
throat, fetal, donor1	10061-101H7	61.86	34.74	32.30	10.36	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	22.66	17.49	12.52	5.17	0.99
thymus, adult, pool1	10027-101D9	20.38	7.16	7.85	1.59	0.50
thymus, fetal, pool1	10043-101F7	30.13	15.38	19.01	4.36	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.66	15.96	8.51	2.66	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	16.20	12.57	7.40	1.82	0.14
thyroid, adult, pool1	10028-101E1	67.84	42.18	53.28	14.37	2.71
thyroid, fetal, donor1	10060-101H6	53.79	30.58	30.32	9.49	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	27.72	15.40	9.24	0.00
tongue, adult	10203-103F5	40.47	10.47	19.07	4.88	1.86
tongue, fetal, donor1	10059-101H5	61.08	28.77	26.40	7.49	4.34
tonsil, adult, pool1	10047-101G2	38.97	10.72	17.43	2.91	1.30
trachea, adult, pool1	10029-101E2	58.81	17.26	31.90	6.87	1.55
trachea, fetal, donor1	10058-101H4	45.39	38.08	31.93	8.85	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	47.12	19.13	11.34	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	23.71	6.18	10.03	1.82	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	50.30	28.67	19.27	5.80	1.25
tridermal teratoma cell line:HGRT	10694-109G1	30.44	51.37	9.51	15.22	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.27	19.72	15.41	4.83	0.93
umbilical cord, fetal, donor1	10057-101H3	50.08	16.69	16.69	6.26	0.00
uterus, adult, pool1	10100-102D1	83.27	46.24	29.18	13.99	2.05
uterus, fetal, donor1	10055-101H1	60.41	51.70	27.64	10.24	1.54
vagina, adult	10204-103F6	63.97	31.66	63.33	20.03	3.23
vein, adult	10191-103E2	35.51	15.12	14.91	6.14	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.34	2.40	0.27	0.27	0.00